Kestrel Life Sciences

← Insights

Security ยท Annex 11

Identity, access and the remote engineer

Multi-factor authentication, least privilege and periodic access review move from good practice to written requirement in the draft Annex 11. Here is how to get there without stopping the plant.

Kestrel Life SciencesOctober 20266 min readStatus at 9 October 2026: Draft Annex 11 expectation.

Access control has always been in Annex 11. What the draft adds is specificity. Accounts are personal and named. Privileges follow the principle of least privilege, with segregation of duties between those who configure a system and those who use it. Access is reviewed on a recurring basis. And remote access to critical systems from outside the controlled network requires multi-factor authentication.

The access lifecycle the draft writes down Named user,least privilegeRequest and approverole defined in advanceProvisionsegregation of dutiesAuthenticate and useMFA for remote critical accessReview periodicallyis the access still needed?Revoke promptlyleavers and role changes
Figure 1. The access lifecycle. Each segment needs a procedure and evidence that it happened.

Where companies usually fall short

Shared and generic accounts on the shop floor

Operator panels, older instruments and line equipment often still use a shared login. Where the equipment cannot support named users, the compensating controls need to be documented and the risk accepted at the right level, with a plan to replace it.

Administrator rights that never expire

Vendor engineers and project teams are granted elevated access for a go-live and keep it. A periodic review that actually removes access, rather than confirming it, is the fix.

Remote support without strong authentication

Supplier remote sessions into process control and MES environments are a known route for both errors and attacks. The draft's MFA expectation aligns GMP with what your security team already wants.

Making it work in practice

Kestrel view

Access control is where IT security and GMP finally want exactly the same thing. Use one process for both and you halve the evidence you have to produce.

Sources and further reading

Regulatory status is stated as at 9 October 2026. Draft texts can change before they are finalised; always work from the current published version.

Working through any of this on a live system?

Tell us the system and the regulation. We will come back to you within one working day.